133 related articles for article (PubMed ID: 11877004)
1. [Protection of hematopoietic stem cells by MIP-1alpha and PF4 against the cytotoxicity of chemotherapeutic agents].
Huang K; Huang S; Pan J; Wu Y
Zhonghua Xue Ye Xue Za Zhi; 2000 Jul; 21(7):355-8. PubMed ID: 11877004
[TBL] [Abstract][Full Text] [Related]
2. Differential response of CD34+ cells isolated from cord blood and bone marrow to MIP-1 alpha and the expression of MIP-1 alpha receptors on these immature cells.
de Wynter EA; Durig J; Cross MA; Heyworth CM; Testa NG
Stem Cells; 1998; 16(5):349-56. PubMed ID: 9766815
[TBL] [Abstract][Full Text] [Related]
3. Macrophage inflammatory protein 1alpha enhances in a different manner adhesion of hematopoietic progenitor cells from bone marrow, cord blood, and mobilized peripheral blood.
Suehiro Y; Muta K; Umemura T; Abe Y; Nishimura J; Nawata H
Exp Hematol; 1999 Nov; 27(11):1637-45. PubMed ID: 10560911
[TBL] [Abstract][Full Text] [Related]
4. CD34++ CD38- and CD34+ CD38+ human hematopoietic progenitors from fetal liver, cord blood, and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source.
Weekx SF; Van Bockstaele DR; Plum J; Moulijn A; Rodrigus I; Lardon F; De Smedt M; Nijs G; Lenjou M; Loquet P; Berneman ZN; Snoeck HW
Exp Hematol; 1998 Oct; 26(11):1034-42. PubMed ID: 9766443
[TBL] [Abstract][Full Text] [Related]
5. Macrophage inflammatory protein 1alpha attenuates the toxic effects of temozolomide in human bone marrow granulocyte-macrophage colony-forming cells.
Clemons M; Watson A; Howell A; Chang J; Heyworth C; Lord B; Testa N; Dexter TM; Margison G
Clin Cancer Res; 2000 Mar; 6(3):966-70. PubMed ID: 10741722
[TBL] [Abstract][Full Text] [Related]
6. Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins.
Gupta P; Oegema TR; Brazil JJ; Dudek AZ; Slungaard A; Verfaillie CM
Blood; 2000 Jan; 95(1):147-55. PubMed ID: 10607697
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors.
Van Ranst PC; Snoeck HW; Lardon F; Lenjou M; Nijs G; Weekx SF; Rodrigus I; Berneman ZN; Van Bockstaele DR
Exp Hematol; 1996 Nov; 24(13):1509-15. PubMed ID: 8950234
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of immature erythroid progenitor cell proliferation by macrophage inflammatory protein-1alpha by interacting mainly with a C-C chemokine receptor, CCR1.
Su S; Mukaida N; Wang J; Zhang Y; Takami A; Nakao S; Matsushima K
Blood; 1997 Jul; 90(2):605-11. PubMed ID: 9226160
[TBL] [Abstract][Full Text] [Related]
9. Platelet factor 4 and other CXC chemokines support the survival of normal hematopoietic cells and reduce the chemosensitivity of cells to cytotoxic agents.
Han ZC; Lu M; Li J; Defard M; Boval B; Schlegel N; Caen JP
Blood; 1997 Apr; 89(7):2328-35. PubMed ID: 9116276
[TBL] [Abstract][Full Text] [Related]
10. Expression of macrophage inflammatory protein-1 receptors in human CD34(+) hematopoietic cells and their modulation by tumor necrosis factor-alpha and interferon-gamma.
Dürig J; de Wynter EA; Kasper C; Cross MA; Chang J; Testa NG; Heyworth CM
Blood; 1998 Nov; 92(9):3073-81. PubMed ID: 9787141
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.
Broxmeyer HE; Sherry B; Cooper S; Lu L; Maze R; Beckmann MP; Cerami A; Ralph P
J Immunol; 1993 Apr; 150(8 Pt 1):3448-58. PubMed ID: 7682242
[TBL] [Abstract][Full Text] [Related]
12. MIP-1alpha and TGF-beta production in CD34+ progenitor-stromal cell coculture systems: effects of progenitor isolation method and cell-cell contact.
Liesveld JL; Harbol AW; Belanger T; Rosell KE; Abboud CN
Blood Cells Mol Dis; 2000 Aug; 26(4):261-75. PubMed ID: 11042027
[TBL] [Abstract][Full Text] [Related]
13. Short-term, serum-free, static culture of cord blood-derived CD34+ cells: effects of FLT3-L and MIP-1alpha on in vitro expansion of hematopoietic progenitor cells.
Capmany G; Querol S; Cancelas JA; García J
Haematologica; 1999 Aug; 84(8):675-82. PubMed ID: 10457401
[TBL] [Abstract][Full Text] [Related]
14. Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
Karlic H; Louda N; Pfeilstöcker M; Keil F; Lohninger A; Pittermann E; Paukovits J
Stem Cells; 2001; 19(4):321-8. PubMed ID: 11463952
[TBL] [Abstract][Full Text] [Related]
15. Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38- cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells.
Kawakami M; Kimura T; Kishimoto Y; Tatekawa T; Baba Y; Nishizaki T; Matsuzaki N; Taniguchi Y; Yoshihara S; Ikegame K; Shirakata T; Nishida S; Masuda T; Hosen N; Tsuboi A; Oji Y; Oka Y; Ogawa H; Sonoda Y; Sugiyama H; Kawase I; Soma T
Leukemia; 2004 May; 18(5):912-21. PubMed ID: 14999295
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of the differential response of normal and CML haemopoietic progenitor cells to macrophage inflammatory protein-1alpha.
Dürig J; Testa NG; Lord BI; Kasper C; Chang J; Telford N; Dexter TM; Heyworth CM
Leukemia; 1999 Dec; 13(12):2012-22. PubMed ID: 10602423
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
[TBL] [Abstract][Full Text] [Related]
18. Correlation of c-kit expression and cell cycle regulation by transforming growth factor-beta in CD34+ CD38- human bone marrow cells.
Morita N; Yamamoto M; Tanizawa T
Eur J Haematol; 2003 Nov; 71(5):351-8. PubMed ID: 14667198
[TBL] [Abstract][Full Text] [Related]
19. [Effect of platelet factor 4 on the adherence of cord blood CD34(+) cells].
Lu SH; Feng Y; Yang RC; Liu YJ; Zhai QL; Zhang ZH; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2003 Sep; 24(9):467-9. PubMed ID: 14575589
[TBL] [Abstract][Full Text] [Related]
20. Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells.
Dao MA; Taylor N; Nolta JA
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13006-11. PubMed ID: 9789031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
